Costello Asset Management’s AbbVie ABBV Stock Holding History

Costello Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	1,269 +1	+0.1%	+$215	0.1%	94
2026 Q1	$276K	Buy	1,268 +1	+0.1%	+$222	0.1%	92
2025 Q4	$290K	Hold	1,267	–	–	0.1%	93
2025 Q3	$293K	Buy	1,267 +1	+0.1%	+$204	0.1%	92
2025 Q2	$235K	Buy	1,266 +29	+2%	+$5.39K	0.09%	100
2025 Q1	$259K	Buy	+1,237	New	+$240K	0.11%	92
2023 Q4	–	Sell	-60	Closed	-$8.94K	–	181
2023 Q3	$8.94K	Hold	60	–	–	0.01%	148
2023 Q2	$8.08K	Sell	60 -40	-40%	-$5.87K	0.01%	147
2023 Q1	$15.9K	Hold	100	–	–	0.02%	130
2022 Q4	$16.2K	Hold	100	–	–	0.01%	133
2022 Q3	$13K	Hold	100	–	–	0.01%	140
2022 Q2	$15K	Hold	100	–	–	0.01%	145
2022 Q1	$16K	Buy	100 +65	+186%	+$9.44K	0.01%	155
2021 Q4	$5K	Sell	35 -176	-83%	-$20.8K	﹤0.01%	192
2021 Q3	$23K	Buy	211 +30	+17%	+$3.43K	0.01%	144
2021 Q2	$20K	Buy	181 +1	+0.6%	+$113	0.01%	145
2021 Q1	$20K	Buy	180 +26	+17%	+$2.78K	0.01%	154
2020 Q4	$16K	Buy	154 +2	+1%	+$192	0.01%	157
2020 Q3	$13K	Buy	152 +2	+1%	+$188	0.01%	145
2020 Q2	$15K	Buy	+150	New	+$13.2K	0.01%	135

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Costello Asset Management's ABBV Position: Q2 2026 in Review

Costello Asset Management increased its AbbVie (ABBV) stake by 0.08% in Q2 2026, buying an estimated $215 and bringing the position to 1,269 shares worth $319K. The position accounts for 0.1% of the portfolio, ranked #94.

Costello Asset Management first reported a position in ABBV in Q2 2020 and has held it in 20 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Costello Asset Management held 1,269 shares of AbbVie worth $319K as of Q2 2026.
Costello Asset Management bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.1% of Costello Asset Management's portfolio in Q2 2026, its #94 holding.
Costello Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 20 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.